A Phase II Safety and Efficacy Study on Prognosis of Moderate Pneumonia in Coronavirus Disease 2019 Patients With Regular Intravenous Immunoglobulin Therapy

The Journal of Infectious Diseases (2021) - Comments
pubmed: 33585890 doi: 10.1093/infdis/jiab098 issn: 0022-1899 issn: 1537-6613

Raman R S, Vijaykumar Bhagwan Barge, Anil Kumar Darivenula, Himanshu Dandu, Rakesh R Kartha, Varun Bafna, Vishaly T Aravinda, Thummala C Raghuram